Fennec Pharmaceuticals (FENC)

• Market cap: $219M
• 1 day: 2.21%
• 5 days: -4.15%
• 1 month: -5.07%
• 3 months: -7.85%
• 6 months: 24.17%
• Year to date: 24.96%
• 1 year: 78.64%
• 5 years: -4.15%
• 10 years: -34.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32